At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to measure critical protein biomarkers from liquid samples that can enable the earliest possible detection of disease. We believe the next frontier in biology is enabled by measuring proteins at higher sensitivity in highly multiplexed assays at the push of a button, which is something only Alamar can do. As we build our team, we seek collaborative, driven, intellectually curious people committed to solving complex challenges. Our culture rewards accountability and cross functional teamwork because we believe this enables the kind of breakthrough thinking that will accelerate our mission.
We seek a highly motivated Scientist to join a dynamic team of professionals in the Technology Access team to support our company mission. In this role, you will work cross-functionally across multiple teams including R&D, Sales and Marketing to design, execute and deliver NULISA immunoassay projects as part of the Technology Access Program. An ideal candidate will have a background in immunology, neuroscience, or proteomics and bring hands-on experience in immunoassay development. The ability to manage complex projects in a fast-paced, collaborative environment is highly preferred.
Primary Responsibilities
- Design, conduct, and analyze NULISA immunoassay experiments to assess various biomarkers across diverse biological matrices.
- Design and optimize assay parameters including sensitivity, specificity, detectability, and precision to execute and deliver NULISA immunoassay projects.
- Troubleshoot technical challenges via root-cause analysis and implement corrective strategies.
- Collaborate closely with cross-functional teams and external stakeholders to ensure the timely and accurate completion of deliverables.
Requirements
- Ph.D. in Biochemistry, Molecular Biology, or a related discipline; M.S. with 3+ years of experience will also be considered or BA/BS with 5+ years of experience
- Hands-on experience in executing and optimizing immunoassays such as ELISA. Experience with high-sensitivity platforms (Simoa, MSD, or Luminex) is a plus but not required.
- Familiarity with molecular biology methods (e.g., qPCR, ddPCR).
- Strong problem-solving and analytical skills with attention to detail in experimental execution.
- Ability to manage time effectively, work collaboratively, and adapt in a fast-paced environment.
- Strong communication skills, including data presentation and technical documentation.
- Knowledge of biomarker research, assay validation, or clinical sample testing is desirable.
The base salary range for this full-time position is $120,000 - $140,000 + bonus + equity + benefits. Our salary ranges are determined by work location, job-related skills, experience, and relevant education or training. The ranges displayed on each job posting reflect the minimum and maximum target for new hire salaries but are subject to change if the leveling of the role is adjusted. Your recruiter can share more about the specific salary range during the hiring process.
Please Note - We participate in E-Verify to confirm authorization to work in the United States.
Alamar Biosciences Fremont, California, USA Office
47071 Bayside Pkwy, Fremont, CA, United States, 94538
Similar Jobs
.png)
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
